Skip to main content

Advertisement

Very rare disorders - organisation of care

Article metrics

  • 1441 Accesses

Care for patients and their families with rare disorders is gradually recognised as being essential both on an individual basis and on a population scale. Attention is usually paid to those with disorders with prevalence between one in 2,000 to one in 100,000. Not many official bodies realise that the majority of patients with rare disorders have in fact disorders that are much rarer, with a prevalence of one in 1,000,000 to one in 100,000,000. This has consequences in providing the best care as the creation of support groups for such rare disorders is much more problematic, and centralisation of care cannot be established on a national level but only on a European level. This has wide-spread consequences, for instance regarding language, insurance, transportation, and research. The use of the internet to establish contacts, create Wikis around such rare entities, and to allow for e-mail consultations with medical experts elsewhere in Europe is emphasised and demonstrated using the entity Marshall-Smith syndrome (30 patients known in Europe) as an example.

The establishment of large centres of excellence for patients with very rare disorders has been suggested, either one in each country or one for around populations of 30,000,000 Europeans, to provide essential care and form a basis for further research.

Author information

Correspondence to Raoul CM Hennekam.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Keywords

  • Public Health
  • National Level
  • Support Group
  • Individual Basis
  • Good Care